Nazli Gad El Mawla

Nazli-Gad-El-MawlaNazli Mohamed Gad-El-Mawla (1929-2001) was an Egyptian oncologist.[1]

Educated at the University of Cairo, Nazli Gad-El-Mawla founded the Department of Medical Oncology at National Cancer Institute Egypt. She was Professor of Oncology there from 1977 to 1989.[1] She was known particularly for her work in the chemotherapy of bilharzialbladder cancer, accounting for around a quarter of all cancer in Egypt, and in hematological malignancies.[2]

The International Network for Cancer Treatment Research has established an award in her memory, the Nazli Gad-el-Mawla Award, for outstanding contributions to cancer control by individuals from countries with limited resources


Mawla, Nazli Mohamed Gad El was born on June 16, 1929 in Cairo, Egypt. Daughter of Mohamed Ahmed Gad El Mawla and Sania Mohamed Sultan.


Bachelor of Medicine, BChir, School Medicine, Cairo, 1952.

Doctor of Medicine in General Medicine, School Medicine, Cairo, 1961.


House officer Cairo University Hospitals, 1953-1954,

rotating intern, 1955-1957.

Research fellow Research Institute, Cairo, 1958-1968.

Tutor School Medicine, 1968-1970.
Assistant professor National Cancer Institute, 1970-1977,

professor medical oncology, since 1977.

Head medical oncology National Cancer Institute, Cairo, 1977-1989.

Consultant Police Hospital, Cairo, since 1980,

Consultant Misr International Hospital, Giza, since 1983.


  • Certified medical oncology.


Member American Society Clinical Oncology,

European Society Medical Oncology,

European School Oncology (national representative).


The Nazli Gad-el-Mawla Award was given for outstanding contributions to cancer control by an individual from a country with limited resources. Nazli Gad-el-Mawla, was a pioneer Egyptian oncologist, who, as a member of a small group of oncologists working at the National Cancer Institute in Cairo in the 1960s and '70s helped to build the institute into one of the premier cancer centers in the Middle East. She founded the Department of Medical Oncology in 1970 and, as part of it, developed a strong pediatric oncology program. She is known particularly for her work in the chemotherapy of cancer of the bilharzial bladder, which accounts for some 25% of all cancer in Egypt, and in hematological malignancies. She was highly respected both by her colleagues in Egypt and also by the international community of oncologists in which she became increasingly active throughout her career.